McCord, M.; Bartom, E.; Burdett, K.; Baran, A.; Eckerdt, F.D.; Balyasnikova, I.V.; McCortney, K.; Sears, T.; Cheng, S.-Y.; Sarkaria, J.N.;
et al. Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts. Cancers 2022, 14, 5494.
https://doi.org/10.3390/cancers14225494
AMA Style
McCord M, Bartom E, Burdett K, Baran A, Eckerdt FD, Balyasnikova IV, McCortney K, Sears T, Cheng S-Y, Sarkaria JN,
et al. Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts. Cancers. 2022; 14(22):5494.
https://doi.org/10.3390/cancers14225494
Chicago/Turabian Style
McCord, Matthew, Elizabeth Bartom, Kirsten Burdett, Aneta Baran, Frank D. Eckerdt, Irina V. Balyasnikova, Kathleen McCortney, Thomas Sears, Shi-Yuan Cheng, Jann N. Sarkaria,
and et al. 2022. "Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts" Cancers 14, no. 22: 5494.
https://doi.org/10.3390/cancers14225494
APA Style
McCord, M., Bartom, E., Burdett, K., Baran, A., Eckerdt, F. D., Balyasnikova, I. V., McCortney, K., Sears, T., Cheng, S.-Y., Sarkaria, J. N., Stupp, R., Heimberger, A. B., Ahmed, A., James, C. D., & Horbinski, C.
(2022). Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts. Cancers, 14(22), 5494.
https://doi.org/10.3390/cancers14225494